Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Hall Chadwick Acquisition Signs $2.1M M&A Deal with REEcycle Holdings, Inc.
Hall Chadwick Acquisition Corp. (HCAC) provided an update on its pending merger with REEcycle Holdings, Inc., announcing it has entered into binding subscription agreements for a $2.1 million PIPE investment. The PIPE involves the sale of 210,000 shares at $10.00 per share to entities managed by directors and advisors of the merging companies. The filing also includes an investor presentation detailing REEcycle's business of building a domestic rare earth supply chain.
Tiaa Real Estate Account $150M Debt Financing with qualified institutional purchasers
TIAA Real Estate Account entered into a note purchase agreement to issue $150 million in 5.84% series F senior unsecured notes due September 28, 2031. The proceeds from the private placement will be used for general corporate purposes, and the notes include customary financial covenants regarding leverage and interest coverage ratios.
First Community Corporation entered into a consulting agreement with retiring executive J. Ted Nissen, effective January 1, 2027. Mr. Nissen will provide transition support and strategic advice through December 31, 2027, receiving $40,000 per month for the first quarter and $15,000 per month for the remainder of the year.
Muzinich Corporate Lending Income Fund Capital Raise of $3M
Muzinich Corporate Lending Income Fund, Inc. sold approximately $3.0 million worth of common stock in an unregistered private placement on October 1, 2026. The shares were sold at a price equal to the company's net asset value (NAV) per share as of September 30, 2026, which is currently being determined.
Hub Group's majority stockholders (the DPY Stockholders) executed a written consent to remove three directors (Michael Flannery, Peter McNitt, and Gary Yablon) and appoint four new directors (Gregory D. Bunch, Thomas P. Fitzgerald, Thaddeus J. Malik, and Thomas M. White). Following this action, three additional directors (Mary H. Boosalis, Jenell Ross, and Martin P. Slark) resigned from the Board, resulting in a significant overhaul of the company's leadership structure.
The Gorman-Rupp Company entered into new Change of Control Severance Agreements with its CEO, CFO, and General Counsel. The agreements provide for lump-sum payments of up to three times base salary plus bonus for the CEO and two times for other executives if terminated following a change of control, alongside accelerated equity vesting and COBRA coverage.
Trilogy Metals reported financial results for the third quarter ended August 31, 2026, showing a comprehensive income of $0.24 million compared to a loss in the prior year. The company highlighted a $31.2 million cash balance and the closing of a $35.6 million strategic equity investment from the Department of War to advance the Upper Kobuk Mineral Projects.
Term
Q3 2026
“The third quarter and the weeks that followed have been transformational for Trilogy Metals. The Department of War's investment in Trilogy was successfully closed. On the permitting front, the Arctic Project now has a transparent, coordinated federal and state schedule, and the Notice of Intent, published on schedule, has formally launched the NEPA review on a path to a Record of Decision in September 2028. With a defined permitting timeline, the investment by the U.S. Government, and a clear line of sight to a Record of Decision, Arctic is well positioned to become a cornerstone of a secure, domestic copper supply chain.”
Tony Giardini, President and CEO of Trilogy Metals
Nayax CEO, Co Founder & Chairman Yair Nechmad Buys $2.11M of Stock
Yair Nechmad, CEO, Co Founder & Chairman, bought 44,148 shares of Nayax Ltd. at $46.39 to $48.56 a share (average $47.84) in 3 transactions, worth $2.11M in total on Sep 30, 2026. Shares held after the trade: 7,524,641 (+0.2%).
Alpha Modus Holdings Nasdaq/NYSE Compliance Notice
Alpha Modus Holdings received a letter from Nasdaq indicating that the company has regained compliance with Listing Rule 5550(b)(1). However, the staff noted that the company must continue to evidence compliance in its next periodic report or it may be subject to delisting.
Freeport-McMoRan provided a Q3 2026 operational update reporting consolidated copper production of 830 million pounds and gold production of 230 thousand ounces, both in line with expectations. Gold sales were lower than estimated due to the deferral of 60,000 ounces of refined gold at PT Freeport Indonesia to the fourth quarter. The company also noted that PTFI’s smelter in Eastern Java successfully re-commenced operations in late August 2026 following a prior suspension.
Scientific Industries entered into a new employment agreement with CFO Zachary Rovinsky and extended the agreements of CEO Helena Santos and Chairman John A. Moore. Mr. Rovinsky will receive an annual salary of $210,000 through September 2028, while Ms. Santos and Mr. Moore's contracts were extended through September 2027 with salaries of $200,000 and $165,000, respectively.
Blue Owl Technology Income Corp. (OTIC) provided a shareholder update reporting a 2.1% quarter-to-date total return for Class I shareholders as of August 31, 2026, and a 9.0% annualized total return since inception. The Fund noted stable credit quality with non-accruals at 0.3% of fair value and reported that estimated repurchase requests for the third quarter totaled $1.1 billion (39.0% of shares outstanding), which will be fulfilled on a 5% pro rata basis.
Blue Owl Credit Income Corp. provided an operational update reporting that it received $3.1 billion in share repurchase requests for Q3 2026, a decrease from previous quarters. The Fund will fulfill its 5% tender offer on a pro rata basis and highlighted its strong liquidity position of $11.2 billion and resilient credit quality with non-accruals at only 0.2% of fair value.
Rivian reported Q3 2026 production of 19,751 vehicles and deliveries of 19,248 vehicles from its Normal, Illinois facility. The company reaffirmed its full-year 2026 delivery guidance of 65,000 to 70,000 vehicles and scheduled its formal Q3 financial results release for October 29, 2026.
David J. Bates, COO, sold 2,615 shares of XPO, Inc. at $175.77 to $179.66 a share (average $177.93) in 4 transactions, worth $465K in total on Oct 1, 2026. Shares held after the trade: 62,120 (-1.1%).
Integra LifeSciences announced preliminary Q3 2026 revenue of $410-$412 million and updated its full-year guidance to reflect a $22-$27 million total revenue impact from flooding at its Cincinnati manufacturing facility. The company expects the facility to return to full operations in Q2 2027 and anticipates insurance recoveries to mitigate a substantial portion of the financial impact.
Century Therapeutics presented updated nonclinical data for CNTY-813, its iPSC-derived islet replacement therapy for type 1 diabetes, at the EASD 2026 meeting. The data demonstrated sustained glycemic control in diabetic mouse models for over eleven months and confirmed manufacturing consistency across five clinical-scale batches. The company remains on track to submit an IND for CNTY-813 in Q4 2026, with initial clinical data expected in the second half of 2027.
Counterparty
European Association for the Study of Diabetes (EASD)
Hyperion DeFi announced it has repurchased 240,124 common shares at a weighted average price of $3.21 per share and voluntarily repaid its entire $8.6 million legacy debt obligation to Avenue Capital. The company funded the debt retirement using proceeds from HYPE token sales and cash on hand, leaving it with zero long-term debt and approximately $14.5 million in cash and stablecoins.
Value
$770K
“The month of September was very exciting for us, having raised guidance, commencing share buybacks, paid down legacy debt, and announced multiple new businesses. We are grateful for Avenue Capital’s long-term support of the Company in its transformation away from Eyenovia, our legacy biotech brand. With the debt fully repaid, we now have more operational flexibility to scale our onchain DeFi businesses, as well as more flexibility to improve our capital structure for the benefit of HYPD common stockholders.”
Hyunsu Jung, Chief Executive Officer of Hyperion DeFi
Surrozen announced that the FDA clearance of its IND application for SZN-8141 triggered a second closing milestone under a previously announced private placement. This second tranche is expected to provide approximately $95.1 million in gross proceeds on or about October 20, 2026, to support clinical development and operations.
Celcuity Inc. has appointed David W. Gryska to its Board of Directors, effective October 1, 2026, increasing the board size to nine members. Mr. Gryska, a former CFO of Incyte and Celgene, will also serve on the Audit and Compensation Committees. His appointment comes as the company transitions to a commercial-stage entity following its first FDA approval for REVTORPYK.
Bally's $560M Debt Financing with WhiteHawk Capital Partners, LP
Bally's Corporation closed an amended and restated loan agreement providing $400 million in fully funded term loans and $160 million in delayed draw commitments. The financing, led by WhiteHawk Capital Partners, will fund pre-construction costs for the $4.0 billion Bally's Bronx integrated casino project. The project is a major strategic development for the company, expected to feature gaming facilities, a hotel, and an event center by 2030.
VerifyMe, Inc. completed its merger with Open World Ltd., with the target surviving as a wholly owned subsidiary and the combined company rebranding as OpenWorld, Inc. In connection with the closing, the company issued 11,686,124 shares of common stock to Legacy OpenWorld equity holders and 300,000 warrants to business partners. The transaction represents a major strategic shift into digital assets and blockchain innovation.
Compass Therapeutics CAO Neil Lerner Buys $18.4K of Stock
Neil Lerner, CAO, bought 20,000 shares of Compass Therapeutics, Inc. at $0.92 a share, worth $18.4K in total on Oct 1, 2026. Shares held after the trade: 420,000 (+5.0%).
CNS Pharmaceuticals held its 2026 Annual Meeting of Stockholders on September 30, 2026, where shareholders elected six directors and ratified MaloneBailey, LLP as the independent auditor. Stockholders also approved an amendment to the 2020 Equity Plan to increase the number of authorized shares by 650,000 and approved executive compensation on an advisory basis.
EchoStar's subsidiary DISH DBS Corporation and its filing entities have emerged from Chapter 11 bankruptcy following the confirmation of a joint prepackaged plan of reorganization. The restructuring resulted in a substantial deleveraging of the DISH DBS entities, reducing aggregate outstanding indebtedness by approximately $4.35 billion through debt restructuring and note repayments. In connection with the emergence, the company entered into several supplemental indentures governing its senior secured and unsecured notes due between 2026 and 2029.
Columbus Acquisition M&A Deal with WISeSat.Space Holdings Corp.
Columbus Acquisition Corp. (CAC) has completed its business combination with WISeSat.Space Holdings Corp., a space technology company focused on secure satellite communications. Following the closing on October 1, 2026, the combined company's ordinary shares will begin trading on the Nasdaq under the ticker symbol 'SAIQ' on October 2, 2026.
BNB Plus Corp. entered into a second amendment to its Registration Rights Agreement with holders of its registrable securities. The amendment removes the company's fixed deadline to file a resale registration statement, replacing it with a 'demand' structure where holders must request a filing, and includes a waiver of any prior non-compliance by the company.
BNB Plus Corp. announced a strategic transition from a passive digital asset treasury model to an operating company focused on institutional technology infrastructure for blockchain and AI. The company also plans to monetize its LineaRx subsidiary, which specializes in enzymatic DNA manufacturing for genetic medicines.